{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:57:25Z","timestamp":1744163845660},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":6064,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1006\/mthe.2000.0029","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:43Z","timestamp":1032378403000},"page":"275-284","source":"Crossref","is-referenced-by-count":28,"title":["Immunogene Therapy for Murine Melanoma Using Recombinant Adenoviral Vectors Expressing Melanoma-Associated Antigens"],"prefix":"10.1016","volume":"1","author":[{"given":"Michael A.","family":"Perricone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten A.","family":"Claussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanne M.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Piraino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Shankara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mthe.2000.0029_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1084\/jem.185.3.453","article-title":"Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma","volume":"185","author":"Bloom","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2000.0029_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.180.1.35","article-title":"A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"180","author":"Coulie","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2000.0029_bib3","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","article-title":"Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/mthe.2000.0029_bib4","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","article-title":"Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/mthe.2000.0029_bib5","first-page":"3124","article-title":"Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy","volume":"54","author":"Robbins","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/mthe.2000.0029_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.183.3.1131","article-title":"Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen","volume":"183","author":"Wang","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2000.0029_bib7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.181.2.799","article-title":"Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes","volume":"181","author":"Wang","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2000.0029_bib8","first-page":"219","article-title":"Vaccine therapy for cancer","volume":"342","author":"Linehan","year":"1994","journal-title":"Ann. Surg. Oncol."},{"key":"10.1006\/mthe.2000.0029_bib9","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jnci\/88.22.1635","article-title":"Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens","volume":"88","author":"Rosenberg","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/mthe.2000.0029_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s001090050133","article-title":"Gene-based strategies for the immunotherapy of cancer","volume":"75","author":"Tuting","year":"1997","journal-title":"J. Mol. Med."},{"key":"10.1006\/mthe.2000.0029_bib11","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1002\/eji.1830251239","article-title":"Long-term humoral and cellular immunity induced by a single immunization with replication-defective recombinant vector","volume":"25","author":"Juillard","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<303::AID-IJC24>3.0.CO;2-A","article-title":"Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A","volume":"67","author":"Warnier","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1006\/mthe.2000.0029_bib13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4049\/jimmunol.156.2.700","article-title":"Antigen-specific tumor vaccines: Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy","volume":"156","author":"Zhai","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/hum.1995.6.10-1343","article-title":"Characterization of an adenovirus gene transfer vector containing an E4 deletion","volume":"6","author":"Armentano","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2000.0029_bib15","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1089\/hum.1996.7.14-1701","article-title":"Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung","volume":"7","author":"Lee","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2000.0029_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/283139a0","article-title":"The pathogenesis of cancer metastasis","volume":"283","author":"Poste","year":"1980","journal-title":"Nature"},{"key":"10.1006\/mthe.2000.0029_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/hum.1997.8.1-45","article-title":"Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung","volume":"8","author":"Kaplan","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2000.0029_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"gp100\/pmel 17 is a murine tumor rejection antigen: Induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2000.0029_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-1759(88)90079-8","article-title":"Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells","volume":"110","author":"Czerkinsky","year":"1988","journal-title":"J. Immunol. Methods"},{"key":"10.1006\/mthe.2000.0029_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-1759(90)90464-7","article-title":"Detection of individual mouse splenic T cells producing IFN-\u03b3 and IL-5 using the enzyme-linked immunospot (ELISPOT) assay","volume":"128","author":"Taguchi","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1006\/mthe.2000.0029_bib21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1089\/hum.1997.8.11-1355","article-title":"Dendritic cell transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination","volume":"8","author":"Wan","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2000.0029_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4049\/jimmunol.156.1.224","article-title":"Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen","volume":"156","author":"Chen","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4049\/jimmunol.159.2.763","article-title":"Human colorectal cancer (CRC) antigen CO17-1A\/GA733 encoded by adenovirus inhibits growth of established CRC cells in mice","volume":"159","author":"Li","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.163.2.699","article-title":"Induction of antitumor immunity using dendritic cells transduced with adenovirus vector encoding endogenous tumor-associated antigens","volume":"163","author":"Kaplan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib25","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jnci\/90.24.1894","article-title":"Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens","volume":"90","author":"Rosenberg","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1006\/mthe.2000.0029_bib26","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1089\/10430349950016555","article-title":"Cellular immune responses of healthy individuals to intradermal administration of an E1\u2013E3-adenovirus gene transfer vector","volume":"10","author":"Harvey","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/mthe.2000.0029_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/cimm.1997.1151","article-title":"Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow","volume":"179","author":"Yang","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib28","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.160.7.3081","article-title":"Cutting edge: Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejection","volume":"160","author":"Celluzzi","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/mthe.2000.0029_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm0597-558","article-title":"Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells","volume":"3","author":"Gong","year":"1997","journal-title":"Nat. Med."},{"key":"10.1006\/mthe.2000.0029_bib30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1084\/jem.183.4.1357","article-title":"Therapy of murine tumors with p53 wild-type mutant sequence peptide-based vaccines","volume":"183","author":"Mayordomo","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1006\/mthe.2000.0029_bib31","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/nm1295-1297","article-title":"Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity","volume":"1","author":"Mayordomo","year":"1995","journal-title":"Nat. Med."},{"key":"10.1006\/mthe.2000.0029_bib32","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.95.13.7374","article-title":"Characterization of genes modulated during pheomelanogenesis using differential display","volume":"95","author":"Furumura","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/mthe.2000.0029_bib33","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/sj.gt.3300668","article-title":"Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma","volume":"5","author":"Hirschowitz","year":"1998","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001600900297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001600900297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T02:53:31Z","timestamp":1680576811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001600900297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S1525001600900297"],"URL":"https:\/\/doi.org\/10.1006\/mthe.2000.0029","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}